Fibrodysplasia ossificans progressiva (FOP) patients, which suffer from heterotopic bone formation, have a gain-of-function mutation in the BMP type I receptor ALK2 (Shore et al., 2006). This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.